Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lexicon Pharmaceuticals

Clinical trials sponsored by Lexicon Pharmaceuticals, explained in plain language.

Lexicon Pharmaceuticals LXRX NASDAQ

A biopharmaceutical company developing treatments for diabetes and other diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 2

Could a diabetes drug help heart muscle disease? large trial underway

Symptom relief Ongoing

This Phase 3 study tests whether the drug sotagliflozin can improve symptoms and daily function in 500 adults with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens. Participants take either the drug or a placebo pill once daily for 26 weeks. The main…

Phase: PHASE3 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief

Last updated Jul 31, 2026 00:00 UTC